SYRE
#1066
Spyre Therapeutics, Inc. - Common Stock
80.4 5 USD
-0.06%
Market Price
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
-6.34%
Monthly Change
-11.42%
6 month change
+18.75%
Year Change
+236.47%
Previous Close
85.9 0
Open
85.1 3
Low
80.4 5
High
85.3 2
Financials
2017
Current report, 06 Mar 2017
Spyre Therapeutics, Inc. current report, 06 March 2017
8-K
Current report, 15 Feb 2017
Spyre Therapeutics, Inc. current report, 15 February 2017
8-K
2016
Annual report, FY2016
Spyre Therapeutics, Inc. annual report, FY2016
10-K
Current report, 09 Nov 2016
Spyre Therapeutics, Inc. current report, 09 November 2016
8-K
Current report, 18 Oct 2016
Spyre Therapeutics, Inc. current report, 18 October 2016
8-K
Quarterly report, Q3 FY2016
Spyre Therapeutics, Inc. quarterly report, Q3 FY2016
10-Q
Current report, 09 Aug 2016
Spyre Therapeutics, Inc. current report, 09 August 2016
8-K
Quarterly report, Q2 FY2016
Spyre Therapeutics, Inc. quarterly report, Q2 FY2016
10-Q
Current report, 19 May 2016
Spyre Therapeutics, Inc. current report, 19 May 2016
8-K
Current report, 19 Apr 2016
Spyre Therapeutics, Inc. current report, 19 April 2016
8-K